Optimisation of Smac mimetics as HIV-1 latency reversing agents

• L. Pache,
• P. Teriete,
• M.D. Marsden,
• A.M. Spivak,
• D. Heimann,
• A.J. Portillo,
• V. Planelles,
• J.A. Zack,
• N.D.P. Cosford,
• S.K. Chanda

Affiliations

L. Pache

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA

P. Teriete

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA

M.D. Marsden

University of California, Los Angeles, Los Angeles, USA

A.M. Spivak

University of Utah School of Medicine, Salt Lake City, USA

D. Heimann

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA

A.J. Portillo

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA

V. Planelles

University of Utah School of Medicine, Salt Lake City, USA

J.A. Zack

University of California, Los Angeles, Los Angeles, USA

N.D.P. Cosford

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA

S.K. Chanda

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA